Dr Reddy’s Laboratories launches a biosimilar of Roche’s Avastin in India

Meha Kumari
  • 0
  • 19 Aug, 2019 5:46 pm

NEW DELHI: Drug firm Dr Reddy’s Laboratories on Monday said has launched a biosimilar of Roche’s Avastin in India indicated for the treatment of various types of cancers. The company’s biosimilar, Versavo, is available in strengths of 100 mg and 400 mg single use vials, Dr Reddy’s elaborated in a statement. The company now has six biosimilar products commercialised in India and various emerging markets and an active development pipeline of several biosimilar products in the oncology and immunology space, it added.


Leave a Reply

Call Now